Spero Therapeutics Inc. (SPRO)
NASDAQ · Healthcare
Spero Therapeutics Inc. Cash on Hand 2016–2025
Spero Therapeutics Inc. annual/quarterly cash on hand history from 2016 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Spero Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 40.3M, a 23.87% decrease year-over-year.
- Spero Therapeutics Inc. cash on hand for 2025 were 40.3M, a 23.87% decrease from 2024.
- Spero Therapeutics Inc. cash on hand for 2024 were 52.9M, a 30.71% decrease from 2023.
- Spero Therapeutics Inc. cash on hand for 2023 were 76.3M, a 30.04% decrease from 2022.
- Spero Therapeutics Inc. cash on hand for 2022 were 109.1M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Spero Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $40 |
| 2024 | $53 |
| 2023 | $76 |
| 2022 | $109 |
| 2021 | $113 |
| 2020 | $85 |
| 2019 | $30 |
| 2018 | $34 |
| 2017 | $87 |
| 2016 | $10 |
| Spero Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $40 |
| 2024-12-31 | $53 |
| 2023-12-31 | $76 |
| 2022-12-31 | $109 |
| 2021-12-31 | $113 |
| 2020-12-31 | $85 |
| 2019-12-31 | $30 |
| 2018-12-31 | $34 |
| 2017-12-31 | $87 |
| 2016-12-31 | $10 |
Spero Therapeutics Inc. Cash on Hand — FAQ
Spero Therapeutics Inc. (SPRO) cash on hand over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SPRO's cash on hand history?
The chart and table above show Spero Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.